Pfizer Inc. (PFE) is primed for evolution with the beta value of 0.72 – Invest Chronicle
Home  »  News   »  Pfizer Inc. (PFE) is primed for evolution with the...

Pfizer Inc. (PFE) is primed for evolution with the beta value of 0.72

Let’s start up with the current stock price of Pfizer Inc. (PFE), which is $38.57 to be very precise. The Stock rose vividly during the last session to $38.70 after opening rate of $37.87 while the lowest price it went was recorded $37.81 before closing at $37.60.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Recently in News on April 15, 2021, Pfizer Invites Shareholders to Attend Virtual-Only 2021 Annual Meeting of Shareholders on April 22. Pfizer Inc. (NYSE: PFE) announced today that shareholders and the general public are invited to access its virtual-only 2021 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 22, 2021. As previously disclosed, this year’s meeting will be held virtually due to continued public health concerns related to the COVID-19 pandemic and to support the health and well-being of our shareholders and other meeting participants. We have designed the virtual Annual Meeting to ensure that our shareholders who attend the virtual Annual Meeting will be afforded comparable rights and opportunities to participate as they would at an in-person meeting. You can read further details here

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!


Pfizer Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $38.70 on 04/16/21, with the lowest value was $33.36 for the same time period, recorded on 02/26/21.

Pfizer Inc. (PFE) full year performance was 13.43%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Pfizer Inc. shares are logging -10.47% during the 52-week period from high price, and 28.75% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $29.96 and $43.08.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 52673880 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Pfizer Inc. (PFE) recorded performance in the market was 4.78%, having the revenues showcasing 4.95% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 209.74B, as it employees total of 78500 workers.

The Analysts eye on Pfizer Inc. (PFE)

During the last month, 5 analysts gave the Pfizer Inc. a BUY rating, 2 of the polled analysts branded the stock as an OVERWEIGHT, 14 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 36.49, with a change in the price was noted +2.38. In a similar fashion, Pfizer Inc. posted a movement of +6.58% for the period of last 100 days, recording 37,582,758 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for PFE is recording 0.63 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.59.

Technical rundown of Pfizer Inc. (PFE)

Raw Stochastic average of Pfizer Inc. in the period of last 50 days is set at 97.57%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 96.23%. In the last 20 days, the company’s Stochastic %K was 90.55% and its Stochastic %D was recorded 87.36%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Considering, the past performance of Pfizer Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 4.78%. Additionally, trading for the stock in the period of the last six months notably improved by 10.42%, alongside a boost of 13.43% for the period of the last 12 months. The shares increased approximately by 5.38% in the 7-day charts and went down by 7.77% in the period of the last 30 days. Common stock shares were driven by 4.95% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.